2-DEMETHOXY-4-METHOXY URAPIDIL(CAS: 34661-79-5)

2-Demethoxy-4-methoxy Urapidil (CAS: 34661-79-5) falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), as well as the European Chemicals Agency (ECHA) REACH regulations. It is also subject to FDA and EPA requirements for chemical substance evaluation and environmental impact assessments. Compliance with these guidelines ensures safe handling and distribution of the compound.

There are several alternatives to 2-Demethoxy-4-methoxy Urapidil in synthesis, including the use of isomers or analogs such as 4-methoxy Urapidil. Common alternative reagents include substituted methoxy groups or other structural modifications. These alternatives can offer similar properties while possibly improving synthesis efficiency or reducing costs.

The market and research trends for 2-Demethoxy-4-methoxy Urapidil (CAS: 34661-79-5) are focused on its potential applications in pharmacology and drug development. Recent studies have explored its use as an analgesic and anti-inflammatory agent. The demand is increasing due to its promising therapeutic properties, leading to more research and development in related fields.

Waste containing 2-Demethoxy-4-methoxy Urapidil (CAS: 34661-79-5) should be handled according to proper laboratory waste management protocols. It is recommended to collect waste liquids in appropriate containers and dispose of them through professional waste disposal services. Incineration may also be an option, but it should be done in compliance with local environmental regulations to minimize environmental impact.